These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29764229)

  • 1. Use of MPH hemostatic powder for electrophysiology device implantation reduces postoperative rates of pocket hematoma and infection.
    Reynbakh O; Akhrass P; Souvaliotis N; Pamidimukala CK; Nahar H; Bastawrose J; Boktor P; Aziz JE; Mehta D; Aziz EF
    Curr Med Res Opin; 2018 Oct; 34(10):1861-1867. PubMed ID: 29764229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pocket related complications following cardiac electronic device implantation in patients receiving anticoagulation and/or dual antiplatelet therapy: prospective evaluation of different preventive strategies.
    Awada H; Geller JC; Brunelli M; Ohlow MA
    J Interv Card Electrophysiol; 2019 Apr; 54(3):247-255. PubMed ID: 30460588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device implantation for patients on antiplatelets and anticoagulants: Use of suction drain.
    Mukherjee SS; Saggu D; Chennapragada S; Yalagudri S; Nair SG; CalamburNarasimhan
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S389-S393. PubMed ID: 30595295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis.
    Tarakji KG; Korantzopoulos P; Philippon F; Biffi M; Mittal S; Poole JE; Kennergren C; Lexcen DR; Lande JD; Seshadri S; Wilkoff BL
    Heart Rhythm; 2021 Dec; 18(12):2080-2086. PubMed ID: 34280568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microporous polysaccharide hemospheres for reducing pocket hematomas after cardiac device implantation in patients on antithrombotic therapy.
    Matsui Y; Higuchi S; Mori F; Takehisa K; Kikuchi K; Kikuchi H; Hirobe K; Maeda R; Tsukamoto K; Saito T; Shoda M; Yamaguchi J
    J Arrhythm; 2024 Oct; 40(5):1150-1157. PubMed ID: 39416235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?
    Beton O; Saricam E; Kaya H; Yucel H; Dogdu O; Turgut OO; Berkan O; Tandogan I; Yilmaz MB
    BMC Cardiovasc Disord; 2016 Apr; 16():73. PubMed ID: 27105588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local gentamicin-collagen sponge reduces cardiovascular implantable electronic device infections and pocket hematoma.
    Monaco C; Barone L; Cammalleri V; Stifano G; Magliano G; Geuna F; Romeo F; Sergi D
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5218-5224. PubMed ID: 35916820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of pocket-related complications following heart rhythm device implantation. D-Stat Hemostat™ versus vacuum drainage].
    Ohlow MA; Buchter B; Brunelli M; Lauer B; Schreiber M; Geller JC
    Herzschrittmacherther Elektrophysiol; 2015 Mar; 26(1):45-51. PubMed ID: 25644275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
    Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMpact of pocKet rEvision on the rate of InfecTion and other CompLications in patients rEquiring pocket mAnipulation for generator replacement and/or lead replacement or revisioN (MAKE IT CLEAN): A prospective randomized study.
    Lakkireddy D; Pillarisetti J; Atkins D; Biria M; Reddy M; Murray C; Bommana S; Shanberg D; Adabala N; Pimentel R; Dendi R; Emert M; Vacek J; Dawn B; Berenbom L
    Heart Rhythm; 2015 May; 12(5):950-6. PubMed ID: 25625720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
    Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
    Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current strategies to minimize postoperative hematoma formation in patients undergoing cardiac implantable electronic device implantation: A review.
    Mehta NK; Doerr K; Skipper A; Rojas-Pena E; Dixon S; Haines DE
    Heart Rhythm; 2021 Apr; 18(4):641-650. PubMed ID: 33242669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
    Alshoubaki O; Al Darabaa Z; Odat O; Qubbaj A; Alhyari R; Alshare S; Ghanma I
    Med Arch; 2021 Feb; 75(1):56-60. PubMed ID: 34012201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
    Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of prophylaxis topical antibiotics in cardiac device implantation.
    Khalighi K; Aung TT; Elmi F
    Pacing Clin Electrophysiol; 2014 Mar; 37(3):304-11. PubMed ID: 24164587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of bacteremia in patients living with cardiovascular implantable electronic devices.
    DeSimone DC; Sohail MR
    Heart Rhythm; 2016 Nov; 13(11):2247-2252. PubMed ID: 27546815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association.
    Traykov V; Bongiorni MG; Boriani G; Burri H; Costa R; Dagres N; Deharo JC; Epstein LM; Erba PA; Snygg-Martin U; Nielsen JC; Poole JE; Saghy L; Starck C; Strathmore N; Blomström-Lundqvist C
    Europace; 2019 Aug; 21(8):1270-1279. PubMed ID: 31209483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I).
    Turagam MK; Nagarajan DV; Bartus K; Makkar A; Swarup V
    J Interv Card Electrophysiol; 2017 Aug; 49(2):197-204. PubMed ID: 28413854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter defibrillator therapy in young individuals: comparison of conventional and subcostal approaches-a single-centre experience.
    Irfan G; Czapla J; Saitoh Y; Ciconte G; Mugnai G; Conte G; Hunuk B; Velagic V; Stroker E; Chierchia GB; Nijs J; La Meir M; Wellens F; Brugada P; De Asmundis C
    Europace; 2017 Jan; 19(1):81-87. PubMed ID: 26893495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.